Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide

Wedel, H. et al. (2009) Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide. European Journal of Heart Failure, 11(3), pp. 281-291. (doi:10.1093/eurjhf/hfn046)

Full text not currently available from Enlighten.

Publisher's URL: http://dx.doi.org/10.1093/eurjhf/hfn046


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:McMurray, Professor John
Authors: Wedel, H., McMurray, J., Lindberg, M., Wikstrand, J., Cleland, J., Cornel, J., Dunselman, P., Hjalmarson, A., Kjekshus, J., Komajda, M., Kuusi, T., Vanhaecke, J., and Waagstein, F.
College/School:College of Medical Veterinary and Life Sciences
College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
Journal Name:European Journal of Heart Failure
ISSN:1388-9842

University Staff: Request a correction | Enlighten Editors: Update this record